Loading clinical trials...

Evaluation of bioMarkErs to Reduce Antibiotics Use in hospitalizeD nEonates | Clinical Trials | Clareo Health

COMPLETEDNANCT03299751

Evaluation of bioMarkErs to Reduce Antibiotics Use in hospitalizeD nEonates

Late-onset neonatal sepsis (LOS), occurring in newborn of at least 7 days of life, is frequently observed in Neonatal Intensive Care Units (NICUs) and potentially severe (mortality, neurologic and res...

Lead sponsor: Hospices Civils de Lyon•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETED

Markers of Platelet Activation foR Identification of Late Onset Sepsis in Preterm Infants

NCT05530330 · Late-Onset Neonatal Sepsis, Necrotising Enterocolitis, and more

UNKNOWNNA

Effect of Kangaroo Care on Heart Rate Variability in Late-onset Neonatal Sepsis

NCT05991648 · Late-Onset Neonatal Sepsis

UNKNOWNPhase 4

Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.

NCT05981079 · Late-Onset Neonatal Sepsis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 4, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment233

Start dateNov 2017

Last updatedSep 4, 2025

Condition

Late-Onset Neonatal Sepsis

Locations shown

Hospices Civils de Lyon

Bron

CHU de Nantes

Nantes

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 4, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions